We aimed to assess the oxidative status, renal function and membrane electrolytes of angiotensin converting enzyme inhibitor captopril. A total of 12 male Albino Wistar rats (200-250 g) were taken and divided into 2 groups (n=6); group I remained untreated; group II treated with 1 mg/kg b.w. of captopril intraperintonealy for 1 day. The effects of captopril on renal function were analyzed in terms of urea and creatinine; oxidative status by tissue and plasma Malonyldialdehyde (MDA) and tissue catalase activity; and electrolytes homeostasis by plasma sodium, potassium, intraerythrocyte sodium, potassium and membrane Na+-K+-ATPase activity. Increased tissue Malonyldialdehyde (MDA), tissue catalase (P<0.01), plasma urea (P<0.05), creatinine (P<0.01), sodium (P<0.01), potassium (P<0.05), intra-erythrocyte Na+-K+-ATPase (P<0.01), while decreased level of intra- erythrocyte sodium (P<0.05), potassium and magnesium level was observed in Captropril- treated rats. The findings explain the antioxidant property of captopril with altered renal function and membrane electrolytes.